| For: | Alvarenga AM, Brissot P, Santos PCJL. Haemochromatosis revisited. World J Hepatol 2022; 14(11): 1931-1939 [PMID: 36483608 DOI: 10.4254/wjh.v14.i11.1931] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i11/1931.htm |
| Number | Citing Articles |
| 1 |
Deepak Mahadule, Arun Gangwar, Ketan J. Purohit, Nihar Ranjan Sarmah, Nandita Yadav, Hemendra Singh, Ajay B. Shelke, Archana M. Navale, Rutika Wakchaure. Hepatic disorders: current insights, therapeutic challenges, and the role of hepatoprotective flora from North Maharashtra. The Egyptian Journal of Internal Medicine 2026; 38(1) doi: 10.1186/s43162-026-00719-7
|
| 2 |
Charlotte Gils, Søren Feddersen. Incorrect Genotyping in a Hemochromatosis Patient Heterozygous for HFE C282Y and Q283P Variants. International Journal of Laboratory Hematology 2026; 48(2) doi: 10.1111/ijlh.70038
|
| 3 |
Claudia Abadía Molina, Nuria Goñi Ros, Ricardo González Tarancón, Luis Rello Varas, Valle Recasens Flores, Silvia Izquierdo Álvarez. Hereditary hemochromatosis: An update vision of the laboratory diagnosis. Journal of Trace Elements in Medicine and Biology 2023; 78 doi: 10.1016/j.jtemb.2023.127194
|
| 4 |
Claudia Abadía Molina, Nuria Goñi Ros, Ricardo González Tarancón, Luis Rello Varas, M. del Valle Recasens Flores, Silvia Izquierdo Álvarez. Hereditary haemochromatosis: Prevalence and characterization of the disease in a tertiary hospital in Aragon, Spain. Medicina Clínica 2024; 163(9) doi: 10.1016/j.medcli.2024.05.015
|
| 5 |
Roshni Pushpa Raghavan, Kirti Theresa Alexander, Shine Sadasivan, Chetan Parmar, Manikandan Kathirvel. Genetic Variants in Liver Cirrhosis: Classifications, Mechanisms, and Implications for Clinical Practice. Journal of Personalized Medicine 2026; 16(1) doi: 10.3390/jpm16010029
|
| 6 |
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki. HFE-Related Hemochromatosis May Be a Primary Kupffer Cell Disease. Biomedicines 2025; 13(3) doi: 10.3390/biomedicines13030683
|
| 7 |
George J. Kontoghiorghes. The Importance and Essentiality of Natural and Synthetic Chelators in Medicine: Increased Prospects for the Effective Treatment of Iron Overload and Iron Deficiency. International Journal of Molecular Sciences 2024; 25(9) doi: 10.3390/ijms25094654
|
| 8 |
Claudia Abadía Molina, Nuria Goñi Ros, Ricardo González Tarancón, Luis Rello Varas, M. del Valle Recasens Flores, Silvia Izquierdo Álvarez. Hereditary haemochromatosis: Prevalence and characterization of the disease in a tertiary hospital in Aragon, Spain. Medicina Clínica (English Edition) 2024; 163(9) doi: 10.1016/j.medcle.2024.05.017
|
| 9 |
Nadia Karina Aguilar Hinojosa, Evelyn Itzamara Figueroa Saavedra. Desensibilización a deferasirox en una paciente con hemocromatosis. Reporte de un caso. Revista Alergia México 2023; 70(3) doi: 10.29262/ram.v70i3.1256
|
| 10 |
Razieh Zarifian Yeganeh, Masoumeh Akbari Kelishomi, Atiyeh Ahmadpour Jenaghard, Banafsheh Salmani, Zohreh Vahidi, Mina Makvand, Maryam Azad, Mahdieh Kooshki, Yassin Bouraqi, Azita Azarkeivan, Hossein Najmabadi, Maryam Neishabury. HFE and Non-HFE Hereditary Hemochromatosis Based on Screening of 854 Individuals: 12 Years of an Iranian Experience. Genetic Testing and Molecular Biomarkers 2024; 28(7) doi: 10.1089/gtmb.2023.0764
|
| 11 |
A. D. Blann, R. G. Dunn. The Molecular Pathology of Non-Malignant Haematological Disease. British Journal of Biomedical Science 2026; 83 doi: 10.3389/bjbs.2026.14743
|